IHC analysis of ~2500 BCa tumour specimens revealed an association of increased METTL14 and CBLL1 with favourable clinical outcomes in BCa and increased METTL3 expression with poor clinical outcomes in hormone receptor negative BCa. The gene discussed is NR4A1; the disease is neoplasm.